BG105127A - Метод за лечение - Google Patents
Метод за лечениеInfo
- Publication number
- BG105127A BG105127A BG105127A BG10512701A BG105127A BG 105127 A BG105127 A BG 105127A BG 105127 A BG105127 A BG 105127A BG 10512701 A BG10512701 A BG 10512701A BG 105127 A BG105127 A BG 105127A
- Authority
- BG
- Bulgaria
- Prior art keywords
- treament
- nicotine addiction
- smoking
- paroxetine
- solvate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретението се отнася до метод за намаляване или спиране на тютюнопушенето, или за предотвратяване на повторно привикване. По метода се прилага нетоксично количество пароксетин или негова фармацевтично приемлива сол или солват.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9812941.4A GB9812941D0 (en) | 1998-06-16 | 1998-06-16 | Method of treatment |
PCT/US1999/013623 WO1999065491A1 (en) | 1998-06-16 | 1999-06-16 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
BG105127A true BG105127A (bg) | 2001-11-30 |
Family
ID=10833832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105127A BG105127A (bg) | 1998-06-16 | 2001-01-08 | Метод за лечение |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1087766A4 (bg) |
JP (1) | JP2002518330A (bg) |
KR (1) | KR20010052895A (bg) |
CN (1) | CN1305379A (bg) |
AP (1) | AP2000002002A0 (bg) |
AU (1) | AU740749B2 (bg) |
BG (1) | BG105127A (bg) |
BR (1) | BR9911150A (bg) |
CA (1) | CA2335236A1 (bg) |
CZ (1) | CZ20004698A3 (bg) |
EA (1) | EA003584B1 (bg) |
GB (1) | GB9812941D0 (bg) |
HU (1) | HUP0102507A3 (bg) |
IL (1) | IL139943A0 (bg) |
NO (1) | NO20006383L (bg) |
NZ (1) | NZ508532A (bg) |
PL (1) | PL345261A1 (bg) |
SK (1) | SK19192000A3 (bg) |
WO (1) | WO1999065491A1 (bg) |
ZA (1) | ZA200007396B (bg) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6645523B2 (en) * | 2000-08-28 | 2003-11-11 | Synthon Bct Technologies, Llc | Paroxetine compositions and processes for making the same |
IL162458A0 (en) | 2001-12-28 | 2005-11-20 | Teva Pharma | A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof |
US20060039975A1 (en) * | 2004-08-20 | 2006-02-23 | Zalman Vilkov | Paroxetine formulations |
FR2926221A1 (fr) * | 2008-01-14 | 2009-07-17 | Tassin Thomas | Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3688827T2 (de) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. |
EP0558679A1 (en) * | 1990-11-24 | 1993-09-08 | BEECHAM GROUP plc | Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
GB9605828D0 (en) * | 1996-03-20 | 1996-05-22 | Smithkline Beecham Plc | Treatment method |
-
1998
- 1998-06-16 GB GBGB9812941.4A patent/GB9812941D0/en not_active Ceased
-
1999
- 1999-06-16 IL IL13994399A patent/IL139943A0/xx unknown
- 1999-06-16 SK SK1919-2000A patent/SK19192000A3/sk unknown
- 1999-06-16 KR KR1020007014240A patent/KR20010052895A/ko not_active Application Discontinuation
- 1999-06-16 AP APAP/P/2000/002002A patent/AP2000002002A0/en unknown
- 1999-06-16 AU AU46885/99A patent/AU740749B2/en not_active Ceased
- 1999-06-16 WO PCT/US1999/013623 patent/WO1999065491A1/en not_active Application Discontinuation
- 1999-06-16 EA EA200100041A patent/EA003584B1/ru not_active IP Right Cessation
- 1999-06-16 HU HU0102507A patent/HUP0102507A3/hu unknown
- 1999-06-16 NZ NZ508532A patent/NZ508532A/en unknown
- 1999-06-16 PL PL99345261A patent/PL345261A1/xx not_active Application Discontinuation
- 1999-06-16 EP EP99930327A patent/EP1087766A4/en not_active Withdrawn
- 1999-06-16 JP JP2000554371A patent/JP2002518330A/ja not_active Withdrawn
- 1999-06-16 CA CA002335236A patent/CA2335236A1/en not_active Abandoned
- 1999-06-16 CZ CZ20004698A patent/CZ20004698A3/cs unknown
- 1999-06-16 BR BR9911150-0A patent/BR9911150A/pt not_active Application Discontinuation
- 1999-06-16 CN CN99807465A patent/CN1305379A/zh active Pending
-
2000
- 2000-12-12 ZA ZA200007396A patent/ZA200007396B/xx unknown
- 2000-12-14 NO NO20006383A patent/NO20006383L/no unknown
-
2001
- 2001-01-08 BG BG105127A patent/BG105127A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
EP1087766A4 (en) | 2001-11-21 |
BR9911150A (pt) | 2001-03-06 |
EA200100041A1 (ru) | 2001-06-25 |
AU740749B2 (en) | 2001-11-15 |
NO20006383D0 (no) | 2000-12-14 |
HUP0102507A2 (hu) | 2002-05-29 |
NZ508532A (en) | 2003-08-29 |
EP1087766A1 (en) | 2001-04-04 |
CZ20004698A3 (cs) | 2002-02-13 |
JP2002518330A (ja) | 2002-06-25 |
AU4688599A (en) | 2000-01-05 |
SK19192000A3 (sk) | 2001-05-10 |
AP2000002002A0 (en) | 2000-12-31 |
HUP0102507A3 (en) | 2003-12-29 |
CA2335236A1 (en) | 1999-12-23 |
CN1305379A (zh) | 2001-07-25 |
IL139943A0 (en) | 2002-02-10 |
GB9812941D0 (en) | 1998-08-12 |
KR20010052895A (ko) | 2001-06-25 |
NO20006383L (no) | 2000-12-14 |
WO1999065491A1 (en) | 1999-12-23 |
PL345261A1 (en) | 2001-12-03 |
ZA200007396B (en) | 2002-02-27 |
EA003584B1 (ru) | 2003-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPN603895A0 (en) | Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids | |
ZA977783B (en) | Method of inhibiting fibrosis with a somatostatin agonist | |
HK1040708A1 (en) | Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use | |
MY127739A (en) | Use of pramipexole for the treatment of addictive disorders | |
BG105534A (bg) | 5ht1 средство и метод за лечение на мигрена | |
MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
RS115204A (en) | Method of promoting smoking cessation | |
HUP0300048A2 (hu) | Transzdermális vagy transzmukozális dohányzásról leszoktató készítmények, melyek nikotintartalmú hatóanyagkombinációt tartalmaznak és alkalmazásuk | |
PT998287E (pt) | Utilizacao de levobupivacaina | |
MY121623A (en) | Methods of preventing breast cancer. | |
MXPA01008993A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
BG105127A (bg) | Метод за лечение | |
HU9700661D0 (en) | Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer | |
MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
AP2000002017A0 (en) | Salts of paroxetine. | |
NO20012226L (no) | Terapeutiske midler for medikamentavhengighet | |
WO2002007733A3 (en) | Method for enhancing bone mineral density gain by administration of raloxifene | |
IL126158A0 (en) | Method for treating substance abuse | |
GB9410482D0 (en) | Tobacco smokers' mouthpiece | |
BRPI0410173A (pt) | composição farmacêutica para a prevenção e tratamento da viciação em nicotina em um mamìfero | |
HUP0103459A2 (hu) | (2S,3S,5R)-2-(3,5-difluorfenil)-3,5-dimetil-2-morfolinol tartalmú, orális adagolási formák hatékony mennyiségű stabilizáló alginsavval | |
PL346342A1 (en) | The use of r(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders | |
YU59102A (sh) | JEDINJENJA KORISNA ZA LEČENJE ILI PREVENCIJU OBOLJENJA U KOJEM UČESTVUJE ALFA-2β-ADRENOCEPTOR | |
GB9825874D0 (en) | Smokeless tobacco,smokeless medicinal tobacco | |
BG105820A (bg) | Метод за подпомагане прекратяване на пушенето |